Study of Xanomeline/Trospium for memory in schizophrenia
Part of Mental health clinical trials.
This trial tests if a new treatment, xanomeline/trospium (XT), can help improve thinking and memory problems in adults with schizophrenia. You would take XT as a tablet alongside your current medication for up to 52 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You have been diagnosed with schizophrenia and take a stable dose of an oral antipsychotic medication for at least 4 weeks.
- You experience some cognitive difficulties (thinking, memory, or attention) that affect your daily life.
- You are not currently suicidal, do not have severe depression or mania, and do not have severe substance or alcohol use disorder.
- You have no major medical problems that would make the study unsafe, such as severe kidney, liver, or heart conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination pill (xanomeline/trospium) for people who started treatment for schizophrenia in the last 5 years, to see if it helps better than their current medicine. You would stop your current antipsychotic and switch to this study drug under close doctor supervision.
This study tests how well people with schizophrenia can switch from their current antipsychotic medication to a new combination drug, xanomeline/trospium, either quickly or slowly over 8 weeks. It may be an option if your current medication causes side effects or is not working well enough.
This study tracks how satisfied people with schizophrenia are with a new combination medicine called xanomeline and trospium chloride (XT). It aims to understand real-world experiences and benefits of this treatment.
This trial tests whether a new oral medication, KarXT, can help prevent a return of schizophrenia symptoms in people who have been stable on treatment. If you've had a hospital stay in the past year and still have some symptoms, you may be able to join.
This study tests a new medicine (KarXT) for schizophrenia, focusing on how it affects urological (bladder and urinary) safety. You'll stop your current antipsychotic and take the study drug to see if it works well and is safe for your urinary system.
This trial tests an investigational drug, KYN-5356, to see if it can improve thinking and memory problems in adults with schizophrenia. You may join if your schizophrenia is stable and you take only one antipsychotic medication.
Hear when a new Schizophrenia; Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.